v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Condensed Consolidated Statements of Operations        
Revenue     $ 1,101  
Operating expenses:        
Research and development $ 10,447 $ 11,584 30,116 $ 29,374
General and administrative 3,593 2,633 10,151 7,544
Total operating expenses 14,040 14,217 40,267 36,918
Loss from operations (14,040) (14,217) (39,166) (36,918)
Other income, net 215 48 458 140
Net loss (13,825) (14,169) (38,708) (36,778)
Accrued dividends on preferred stock   (121)   (3,681)
Net loss applicable to common stockholders $ (13,825) $ (14,290) $ (38,708) $ (40,459)
Net loss per share applicable to common stockholders - basic and diluted $ (0.53) $ (0.65) $ (1.54) $ (4.44)
Weighted-average number of common shares used in net loss per share applicable to common stockholders - basic and diluted 26,259,216 22,012,743 25,100,278 9,110,993

Source